Showing results (1371-1380 of 1,498) with videos related to

Sort By:
Pageof 150
American Heart Journal|May 15, 2018
A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trialJonathan P Piccini, Stuart J Connolly, William T Abraham, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 16, 2021
Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on European emergency departmentsÒscar Miró, William S Waring, Paul I Dargan, et al.
Nature Genetics|July 27, 2010
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemiaChristopher T Johansen, Jian Wang, Matthew B Lanktree, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 21, 2011
An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemiaChristopher T Johansen, Jian Wang, Matthew B Lanktree, et al.
JACC. Heart Failure|July 1, 2017
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Jianjian Gong, et al.
European Journal of Heart Failure|August 17, 2018
Heart failure with preserved ejection fraction in AsiaJasper Tromp, Tiew-Hwa Teng, Wan Ting Tay, et al.
The New England Journal of Medicine|April 11, 2014
Spironolactone for heart failure with preserved ejection fractionBertram Pitt, Marc A Pfeffer, Susan F Assmann, et al.
ESMO Open|February 5, 2026
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLCN Girard, J Bar, P Baas, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 23, 2025
Biomarker Analysis from the Compass Claudication Study - Rivaroxaban for Intermittent ClaudicationKaren Falcão Britto, Roberto Augusto Caffaro, Giuliano Giova Volpiani, et al.
European Journal of Heart Failure|June 16, 2020
Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HFPooja Dewan, Scott D Solomon, Pardeep S Jhund, et al.
Pageof 150